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Abstract: 
The present study focused on central nervous system (CNS) transport kinetics of manganese phosphate and 
manganese sulfate; these findings were correlated with the transport kinetics of manganese chloride (MnCl2), a 
model Mn compound that has been previously studied. A series of studies was performed to address the 
transport of Mn salts in confluent cultured endothelial cells. The initial rate of uptake (5 min) of Mn salts 
(chloride, sulfate, and phosphate) in rat brain endothelial (RBE4) cell cultures is salt-dependent, with the 
highest rates of uptake for Mn chloride and Mn sulfate (as reflected by the greatest displacement of 
54
Mn 
compared with control). Mn phosphate had a lower rate of uptake than the other two Mn salts. These data show 
that brain endothelial cells efficiently transport Mn sulfate. 
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Article: 
Introduction 
Mn is an essential nutrient, which is especially critical during development (Hurley, 1981). Both the adult brain 
and the developing brain of the fetus normally contain a small amount of Mn (Cotzias et al., 1968). While Mn 
deficiency during development is associated with convulsive disorders (Papavasiliou, 1978; Papavasiliou et al., 
1979; Tanaka, 1982), exposure to elevated levels of Mn in adulthood results in an irreversible brain disease 
characterized by prominent psychological and neurological disturbances (Cotzias et al., 1968; Barbeau et al., 
1976). 
 
Approximately 80% of Mn in plasma is bound to β1-globulin and albumin (Foradori et al., 1967), and a smaller 
fraction of Mn is bound to transferrin (Tf). Mn binding to Tf is time-dependent (Aschner and Aschner, 1990; 
Aschner and Gannon, 1994; Aschner et al., 1999). When complexed with Tf, Mn is exclusively present in the 
trivalent oxidation-state (Aisen et al., 1969). At normal plasma Fe concentrations (0.9— 2.8 μg/ml), iron 
binding capacity (2.5-4 μg/ml), and Tf concentration (3 mg/ml, with two metal—ion-binding sites per molecule 
(Mr, 77,000), of which only 30% are occupied by Fe
3+
) , Tf has 50 μmol/l of unoccupied Mn
3+
 binding sites. Tf 
receptors are present on the surface of the cerebral capillaries (Fishman et al., 1985; Jeffries et al., 1984; 
Partridge et al., 1987) where endocytosis of Tf is known to occur (Partridge et al., 1987). Support for receptor-
mediated endocytosis of a Mn-Tf complex in cultured neuroblastoma cells (SHSY5Y) is provided by Suarez 
and Eriksson (1993). 
 
Ligands for Mn
2+
 other than Tf must exist, however, because plasma that is saturated with Fe
2+
, Zn
2+
, and Cd
2+
 
will bind Mn
2+
 (Scheuhammer and Cherian, 1985). A recent study (Dickinson et al., 1996) has addressed the 
tissue distribution of injected 
54
Mn (MnCl2) in hypotransferrinemic (Hp) mouse mutants. This mouse has a 
mutation in the Tf gene and produces <1% of normal (wild-type animals) Tf levels. 
54
Mn accumulated at 
abnormally high levels in the Hp mouse liver, yet its distribution in the central nervous system (CNS) was not 
altered. These results reveal that Tf is probably required for proper targeting of Mn from the liver to other 
organs, but indicate that non-Tf transport mechanisms for Mn must also exist. 
 
Unlike many other metals, Mn
2+
 does not possess high affinity for any particular endogenous ligand. There is 
almost no tendency for Mn
2+
 to complex to -SH groups or to amines. Not surprisingly, Mn
2+ 
does not have 
much variation in its stability constants for endogenous complexing ligands (log10k = 3, 4, 3, and 3 for glycine, 
cysteine, riboflavin, and guanosine, respectively, where k is the affinity constant). It is likely that minute 
amounts of Mn
2+ 
in plasma exist, according to the Mass Law Principal, as a chloride complex. While the 
amount of this complex in plasma at any one time must be minute, the Mass Law Principal states that a definite 
infinitesimal amount is always present. It also holds that if any Mn
2+
 should leave the plasma by dissolving in a 
lipid membrane, that the protein-Mn
2+
 complex should dissociate to maintain equilibrium. 
 
An important process in the toxic outcome of metals is their transport from plasma into the brain across the 
capillary endothelial cells that comprise the blood-brain barrier (BBB). In order to cross this barrier, metal 
complexes must be either highly lipid soluble, or possess affinity for specific carrier-mediated transport systems 
within the endothelial cell plasma membrane. Little is known about manganese chloride transport, and virtually 
no experimental data exist regarding the transport mechanisms of manganese sulfate and phosphate across the 
BBB, a crucial step in Mn accumulation in the CNS. 
 
Howand in what chemical form Mn is transported across the BBB remains controversial. It appears that 
facilitated diffusion (Rabin et al., 1993), active transport (Murphy et al., 1991; Aschner and Gannon, 1994; 
Rabin et al., 1993) as well Tf-dependent transport (Aschner and Gannon, 1994; Ueda et al., 1993) mechanisms 
are all involved in the transport of Mn across the BBB. Although, non-protein-bound Mn enters the brain more 
rapidly than Tf-bound Mn (Murphy et al., 1991; Rabin et al., 1993), the question remains as to which form 
represents the predominant mechanism of transport in vivo. At physiological Mn plasma concentrations, it is 
postulated that Mn transport across the BBB occurs both as a Tf-Mn conjugate (where Mn is in the 3+ oxidation 
-state) and as Mn
2+
. Both are saturable transporters. A third transport system for Mn represents a leak pathway, 
presumably via circumventricular organs or choroid plexus. Since albumin or α2-macroglobulin are excluded 
from transport across the BBB, Mn
2+
 bound to these plasma-binding proteins does not cross the BBB (unless 
the integrity of the BBB is compromised). As the plasma Mn concentration increases, Mn transport via the 
saturable transport systems and the leak pathway increases. However, since the transporters of Tf-Mn
3+
 
conjugates and Mn
2+
 are saturable, their transport capacity is limited. Therefore, the leak-pathways become the 
predominant mode of Mn transport at high blood Mn concentrations, such as those described in bolus injection 
experiments. 
 
Mn TRANSPORT IN CULTURED RAT BRAIN ENDOTHELIAL (RBE4) CELLS 
The development of in vitro BBB models, consisting of cultured brain endothelial cells, has made possible the 
study of BBB transport phenomena at the cellular level. Basic characteristics of BBB transport of endogenous 
and exogenous solutes and their biochemical, pharmacological, ontogenic and pathological regulation 
mechanisms are, therefore, amenable to investigations. 
 
Immunohistochemical and morphological assessments were carried out in RBE4 cells, kindly provided by 
Neurotech SA, Evry, France. The RBE4 cells were prepared from second-passage RBE4 cell primary cultures 
by transfection with the plasmid pE1A neo. This plasmid carries the entire E1A region of adeno-virus-2 
conferring immortalization without oncogenic transformation, and the neo gene for resistance to the 
aminoglycoside G418 (geneticin; Durieu-Trautmann et al., 1993; Roux et al., 1993, 1994). These cells have 
been previously characterized for functional expression of the serotonin transporter (Brust et al., 2000), evoked 
acetylcholine release (Malo et al., 1999), Mrp1 multidrug resistance-associated protein and p-glyco-protein 
expression (Begley et al., 1996; Regina et al., 1998), γ-glutamyl transpeptidase and alkaline phosphatase 
activities (Roux et al., 1994), as well as production of vasoactive substances (Kis et al., 1999). These cells 
express cell markers specific to endothelium, including Factor VIII and angiotensin-converting enzyme activity, 
and low-density lipoprotein incorporation. Like endothelial cells in vivo, lateral membranes of adjacent cells 
overlap, and their plasma membranes form an extensive network of tight junctions, characteristic of the BBB. 
Notably, RBE4 cells, like cultured bovine brain endothelial cells, express transferrin receptors (TfR; Huwyler et 
al., 1999). 
 
RBE4 cells were cultured and assessed for expression of Factor VIII. Briefly, the cells are seeded at a density of 
10
3
-10
4
 cells/cm
2
 on glass coverslips (for morphological characterizations) or six-well plates (for transport 
studies; see below) coated with rat-tail type-I collagen. The cells were grown in culture medium consisting of 
(α)-minimal essential medium/Ham's F10 (1:1 vol/vol; GIBCO), supplemented with 2 mmol/l glutamine, 10% 
heat-inactivated fetal calf serum, 1 ng/ml basic fibroblast growth factor, and 300 μg/ml geneticin (G418; 
Boehringer Mannheim) in humidified 5% CO2/95% air at 37 °C. In the six-well cell culture plates the cells 
reach confluence after 2 days. The experiments were conducted at confluence with cell densities between 10
5
 
and 10
6
 cells per well (~100-150 μg of protein). Immunohistochemical staining of the RBE4 cell monolayer was 
carried out with HRP-conjugated Factor VIII-related antigen (von Willebrand Factor, Dako Corp.), and attested 
to the endothelial nature and purity of the cultures. 
 
A series of studies was performed to address the transport of Mn salts in confluent cultured endothelial cells (48 
h post-plating). In control cultures, 0.3 μCi [
54
Mn]-MnCl2 was added to the medium and Mn uptake was 
determined at 5 min (DPM standardized for protein content, and expressed as 100%). In the other experimental 
conditions, Mn chloride, Mn sulfate, or Mn phosphate (each at 100 μM) were added to the brain endothelial 
monolayer simultaneously with 0.3 μCi [
54
Mn]-MnCl2, and 
54
MnCl2 uptake was deter-mined (expressed as 
percent uptake versus control). The initial rate (5 min) of Mn uptake was salt-dependent, with the highest rates 
of uptake for Mn chloride and Mn sulfate (as reflected by the greatest displacement of 
54
Mn compared with 
control); Mn phosphate exhibited a lower uptake rate. Similar studies were also conducted with 50 μM of the 
various Mn salts in the medium. Additional studies utilizing analogous techniques have further established that 
there are no qualitative differences in the absolute uptake and rank order of the various Mn salts between 
endothelial cells and astrocytes. Notably, both with 50 and 100 μM Mn salts, the rate (% Mn uptake versus 
control), and the rank order of transport of Mn salts were identical to those in astrocytes and bovine brain 
endothelial cells, with the highest transport for Mn chloride and Mn sulfate, and greater than Mn phosphate. 
Together, these data corroborate observations by Dorman (personal communication) that brain concentrations 
of Mn in rats repeatedly (14 days) exposed to Mn phosphate or sulfate (0-3 mg Mn/m
3
) were significantly 
higher in the Mn sulfate-exposed group (no studies were conducted with inhaled Mn chloride). 
 
Given the differential ability of the various Mn salts to displace 
54
MnCl2 uptake in all the examined cell types, 
the data are inconsistent with mere diffusion of Mn, attesting to an active or carrier-mediated mechanism. We 
recognize that these results do not provide unequivocal proof for differential uptake of Mn in vivo; the only 
approach to prove or disprove the hypothesis of differential uptake of the various salts is to embark upon the in 
vivo studies. Though unlikely, it will also be important to establish in future studies whether the speciation of 
Mn in blood differs upon oral or inhalation exposure to various Mn salts. 
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